• Our offerings
    • Market Access Strategy, HTA, and Health Economics
    • Nordic RWE & Evidence Generation
    • AI & Dashboard Solutions
    • Policy Shaping & Life Science Consulting
  • Our work
  • The latest
  • Our people
  • Careers
  • Contact us

Lif urges five priorities for Denmark’s next government

Danish Cancer Society warns MFN could slow access in Denmark

EFPIA report warns Europe is losing life sciences ground

Nye metoder to brief suppliers on new device process

Janus Laust Thomsen joins Denmark’s medicines council

Bestillerforum reviewed nine methods and updated two cases

Norway agrees Hemgenix after new negotiated price

Denosumab biosimilars: Danish council urges cheapest choice

Medicinrådet launches real-world data pilots in oncology

Previous 1 … 3 4 5 6

Leveraging Nordic data & insights to support your Market Access goals.

NHTA Copenhagen
Nelson Mandelas Allé 14, 2450 Copenhagen SV, Denmark

NHTA Stockholm
Vasagatan 10, 5th floor, 111 20 Stockholm, Sweden

Contact us

+45 44 222 777
CVR: 39842882

+46 70-322 66 65
Org.nr: 559438-4207

contact@nhta.com

Navigation

  • Our offerings
  • Our work
  • The latest
  • Our people
  • Careers
  • Contact us

Follow us on LinkedIn

LinkedIn
  • Data Protection Policy
  • Cookie Policy